Wall Street ended the week on a weaker note, pressured by a selloff in Nvidia (NVDA) following its fiscal fourth-quarter results and outlook.
Sentiment was further weighed down by a hotter-than-expected Producer Price Index reading, which stoked inflation concerns, even as the benchmark U.S. 10-year Treasury yield (US10Y) fell below 4% for the first time in three months.
For the week, the S&P (SP500) lost -0.4%, while the tech-heavy Nasdaq Composite (COMP:IND) dipped -1.0%, and the blue-chip Dow (DJI) fell -1.3%.
Here’s what caught investor attention this week:
Netflix (NFLX) announced that it will not raise its bid for Warner Bros. Discovery (WBD) after the media giant’s board deemed a sweetened, all‑company takeover offer from Paramount Skydance (PSKY) as “superior.” The streaming company said a higher price for Warner Bros. (WBD) was no longer financially attractive. The revised Paramount (PSKY) offer was at a purchase price of $31.00 per share in cash, a one-dollar increase from its earlier bid, which valued the company at around $108B.
Nvidia (NVDA) shares fell nearly 5.5% Thursday, their worst day since April 16, despite posting blowout earnings. The performance highlights the market’s heightened sensitivity to earnings from large-cap technology companies, particularly those tied to artificial intelligence and data center demand.
Block (XYZ) announced on Thursday that it’s slashing its headcount by more than 40% because intelligent technology means fewer people can do more. The company’s stock jumped 24% with the news. Meanwhile, the company issued strong guidance for 2026 and the first quarter of the year, and Q4 earnings merely matched the Wall Street consensus.
IBM (IBM) plunged more than 13% in a single session on Monday, marking the company’s largest one‑day percentage drop since October 2000. The sharp sell‑off was triggered by investor concerns that Anthropic’s Claude Code tool can automate modernization of COBOL, a legacy programming language heavily tied to IBM’s mainframe business.
Advanced Micro Devices (AMD) announced a deal with Meta Platforms (META) to deploy up to 6 gigawatts of AMD Instinct chips to power Meta’s next generation of AI infrastructure. The companies said the multi-year, multi-generation agreement expands their existing strategic partnership and aligns roadmaps across silicon, systems, and software to deliver AI platforms purpose-built for Meta’s workloads.
Novo Nordisk (NVO) shares fell over 15% on Monday after the company’s next-generation obesity drug CagriSema delivered less weight loss than Eli Lilly’s (LLY) competing treatment in a phase 3 trial, raising new concerns about its sales potential. Patients taking a standard dose of CagriSema lost 20.2% of their body weight after 84 weeks, compared with 23.6% for Lilly’s tirzepatide.
Hims & Hers Health (HIMS) fell after the telehealth company’s guidance fell below the consensus. The telemedicine provider sees Q1 revenue of $600-$625M. Consensus is $652.59M. For full-year 2026, revenue is projected at $2.7B-$2.9B. Consensus is $2.71B.
First Solar (FSLR) fell after the company reported a 2026 net sales forecast which missed the average analyst estimate. The company projected full-year revenues of $4.9B-$5.2B, likely below the $5.2B total for 2025 and far below the $6.16B FactSet analyst consensus estimate, on a volume of 17.0-18.2 GW of modules sold after selling 17.5 GW of modules in FY 2025.
IonQ (IONQ) shares rose after the quantum computing company reported fourth-quarter results that were above Wall Street’s estimates. For the period ending Dec. 31, IonQ said it lost an adjusted $0.20 per share as revenue soared 429% to come in at $61.89M. Analysts had expected the company to lose an adjusted $0.23 per share on $40.3M in revenue.
CoreWeave (CRWV) fell after the AI infrastructure software company reported a bigger-than-expected loss and boosted capital expenditures. For the quarter ended December 31, the hyperscaler reported an adjusted loss per share of $0.89 versus the consensus estimate loss per share of $0.72. For 2026, CapEx is expected in the range of $30B to $35B, with the company planning to double active power capacity to more than 1.7 gigawatts by year-end.